CoChat

Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials

Open access
Virumbrales-Muñoz, María, Chen, Jiong, Ayuso, Jose, Lee, Moonhee, Abel, E. Jason, Beebe, David J. · 2020 · Lab on a Chip

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Abstract

Clear cell renal cell carcinoma (ccRCC) is a common genitourinary cancer associated with the development of abnormal tumor angiogenesis. Although multiple anti-angiogenic therapies have been developed, responses to individual treatment are highly variable between patients. Thus, the use of one-patient clinical trials has been suggested as an alternative to standard trials. We used a microfluidic device to generate organotypic primary patient-specific blood vessel models using normal (NEnC) and tumor-associated primary CD31+ selected cells (TEnC). Our model was able to recapitulate differences in angiogenic sprouting and vessel permeability that characterize normal and tumor-associated vessels. We analyzed the expression profile of vessel models to define vascular normalization in a patient-specific manner. Using this data, we identified actionable targets to normalize TEnC vessel function to a more NEnC-like phenotype. Finally, we tested two of these drugs in our patient-specific models to determine the efficiency in restoring vessel function showing the potential of the model for single-patient clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/d0lc00252f

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 51 references

Research works printed but not linked: 3

  1. Rojiani, 2010, Int. J. Clin. Exp. Pathol., 3, 775
  2. Keisner, 2011, Drugs, 71, 443
  3. Huxley, 1987, Am. J. Physiol., 252, H188

Cited by

See all 39

Metadata

Authors
Virumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J.
Affiliations
  • Department of Pathology and Laboratory Medicine
  • University of Wisconsin–Madison (US)
  • Department of Urology
  • University of Wisconsin System (US)
Corresponding author
Beebe, David J.
Venue
Lab on a Chip
Published
2020
Volume
20
Issue
23
Pages
4420-4432
ISSN
  • 1473-0189 (ISSN-L)
  • 1473-0197
OpenAlex
W3094590133
Cited by
39
References
51
Citations by year
2026: 2 · 2025: 8 · 2024: 6 · 2023: 8 · 2022: 11 · 2021: 4
FWCI
1.86
Type
journal article
Language
en
Open access
Locations
  • Lab on a Chip (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Wisconsin Carbone Cancer Center (P30 CA014520)
  • NIH Clinical Center (Moonshot Grant NCI R33CA225281)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
clear cell renal cell carcinoma, patient-specific models, tumor angiogenesis, anti-angiogenic therapy, vascular normalization, CD31+ endothelial cells, microfluidics, angiogenic sprouting, vascular permeability, actionable targets
MeSH terms
Carcinoma, Renal Cell, Humans, Immunotherapy, Kidney Neoplasms, Neovascularization, Pathologic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials. https://app.cochat.ai/papers/10.1039/d0lc00252f
The paper
Virumbrales-Muñoz, M., Chen, J., Ayuso, J., Lee, M., Abel, E. J., & Beebe, D. J. (2020). Organotypic primary blood vessel models of clear cell renal cell carcinoma for single-patient clinical trials. Lab on a Chip. https://doi.org/10.1039/d0lc00252f

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.